You are on page 1of 38

U.S.

FDA Approach to Auditing Including QSIT


Christine Nelson Center for Devices & Radiological Health Food & Drug Administration
25 Sept. 2003 Frankfurt, Germany 1

FDA-Speak Terms
 Inspection = Audit  Investigator = Auditor

25 Sept. 2003

Frankfurt, Germany

Why does FDA inspect device manufacturers?


 To evaluate compliance with the

following FDA device regulations:  Quality Systems  Medical Device Reporting  Medical Device Tracking  Reports of Corrections and Removals  Registration and Listing
25 Sept. 2003 Frankfurt, Germany 3

Who conducts inspections for FDA?


1. FDA investigators in 20 FDA District

Offices around the U.S.


2. FDA-trained Auditors from Conformity

Assessment Bodies in the European Union (EU)


3. In the future, FDA-trained auditors from

independent third parties accredited by FDA


25 Sept. 2003 Frankfurt, Germany 4

How does FDA decide who to inspect?


 Registration database identifies who

manufactures devices for distribution in the U.S.


 Listing database identifies what devices

they distribute
 FDA prioritizes inspections by risk and

gives higher risk devices/situations a higher priority


25 Sept. 2003 Frankfurt, Germany 5

What is high priority for inspection?


 Device manufacturers that:
 Make  Make

class III devices

implantable devices and life supporting and life sustaining devices introduced a new device to the market

 Recently  Have

had significant violations in the


Frankfurt, Germany 6

past
25 Sept. 2003

Does FDA notify the manufacturer of an upcoming inspection?


 FDA calls domestic manufacturers about

5 days before the inspection


 FDA contacts foreign manufacturers 2 - 3

months in advance to schedule inspection


 Manufacturer is requested to send Quality

System Manual or equivalent for preinspection review


25 Sept. 2003 Frankfurt, Germany 7

What happens when the FDA investigator arrives at the site?


 The FDA investigator will:
 Ask

to see the top management

 Present

credentials (identifies person as an FDA investigator) notice of inspection explaining FDAs legal authority to inspect (only in the U.S.)
Frankfurt, Germany 8

 Issue

25 Sept. 2003

What happens during the inspection?


 Investigator may tour the facility to get

an idea of layout, workflow, and areas that may need closer inspection
 This helps the investigator

decide how to organize the inspection


25 Sept. 2003 Frankfurt, Germany 9

What happens next?


 The investigator will:
 Ask

about size and structure of company, who is in charge, what products are manufactured there  Review registration and listing  Evaluate compliance with FDA regulations using the Quality System Inspection Technique (QSIT)
25 Sept. 2003 Frankfurt, Germany 10

What is QSIT?
www.fda.gov/ora/in spect_ref/igs/qsit/q sitguide.htm
FOO D AND DR UG ADMINISTRATION

GUIDE TO INSPECTIONS OF QUALITY SYSTEMS

August 1999

25 Sept. 2003

Frankfurt, Germany

11

What is QSIT?
 Identifies 4 major subsystems to

evaluate and states the purpose and importance of each subsystem


 Provides flowcharts and inspectional

objectives to cover during inspection


 Offers advice  Provides tables for statistical sampling

of records for review


25 Sept. 2003 Frankfurt, Germany 12

What are the four main subsystems?


Corrective & Preventive Actions

Design Controls

Production & Process Controls

Management Material Controls Equipment & Facility Controls

Records, Documents, & Change Controls


Frankfurt, Germany

25 Sept. 2003

13

What does FDA look for in the Management Subsystem?


 Quality Policy established?  Management representative

appointed?
 Management reviews conducted?

25 Sept. 2003

Frankfurt, Germany

14

What does FDA look for in the Management Subsystem?


 Quality audit procedures

established and quality audits conducted?


 Quality plan established?  Quality system procedures

established?
25 Sept. 2003 Frankfurt, Germany 15

What does FDA look for in the Design Control Subsystem?


 Design procedures and plan established?  Design inputs or requirements for device

identified?
 Design outputs or specifications for

device identified?
 Design verification conducted?  Design validation conducted?
25 Sept. 2003 Frankfurt, Germany 16

What does FDA look for in the Design Control Subsystem?


 Software validation completed?  Risk analysis carried out?  Design reviews conducted?  Design transfer to manufacturing

completed successfully?
25 Sept. 2003 Frankfurt, Germany 17

What does FDA look for in the Corrective and Preventive Action Subsystem?
 CAPA procedures established?  Sources of data analyzed to identify

nonconforming product and quality problems?


 Statistical analysis across data

sources?
 Investigations conducted to identify root

cause of failures?

25 Sept. 2003

Frankfurt, Germany

18

What does FDA look for in the Corrective and Preventive Action Subsystem?
 Nonconforming product controlled?  Appropriate corrective actions and

preventive actions carried out?


 Those responsible are told about CAPA

activities?
 Management review of CAPA activities?

25 Sept. 2003

Frankfurt, Germany

19

What does FDA look for in the Production and Process Control Subsystem?
 Processes are controlled and

monitored?
 Any rejects or nonconforming

product?
 Equipment adjusted, calibrated and

maintained?
25 Sept. 2003 Frankfurt, Germany 20

What does FDA look for in the Production and Process Control Subsystem?
 Manufacturing processes validated

or fully verified?
 Software validated?  Production employees trained and

qualified?

25 Sept. 2003

Frankfurt, Germany

21

What about the other subsystems?


 The other three subsystems are covered

through links with the four main subsystems:


 Records,  Facility

documents and change control

and equipment control control

 Material

25 Sept. 2003

Frankfurt, Germany

22

What happens at the end of the inspection?


 The investigator will:
 Meet

with management to discuss the inspection the FDA 483 list of observations of any significant deficiencies the deficiencies
Frankfurt, Germany 23

 Present

 Discuss
25 Sept. 2003

What should the manufacturer do after the inspection?


 Send a letter to FDA identifying how they

have corrected deficiencies or will correct them


 Provide documentation of any corrections

that have been completed


 Provide a timetable or estimated

completion date for future corrections


25 Sept. 2003 Frankfurt, Germany 24

Where should I send the letter?


Office of Compliance Center for Devices and Radiological Health (CDRH) Food and Drug Administration 2094 Gaither Road, HFZ-300 Rockville, Maryland 20850 U.S.A.
25 Sept. 2003 Frankfurt, Germany 25

Center for Devices & Radiological Health


Office of the Center Director Office of Device Evaluation Office of Compliance Office of Science & Technology Office of Health & Industry Programs Division of Small Manufacturers, International & Consumer Assistance
25 Sept. 2003

Office of In Vitro Diagnostic Device Evaluation & Safety Office of Surveillance & Biometrics Office of Systems & Management

Frankfurt, Germany

26

Office of Compliance
Division of Enforcement A
 Dental, ENT &

Division of Enforcement B
 Cardiovascular &

Ophthalmic Devices
 OB/GYN, Gastro &

Neurological Devices
 Diagnostic X-ray

Urology Devices
 General Hospital

Devices
 Electronic Products &

Devices
 General Surgery

Devices
 Orthopedic, Physical

Devices
25 Sept. 2003

Medicine & Anesthesiology Devices


Frankfurt, Germany 27

What happens next?


 Investigator writes an Establishment Inspection

Report or EIR
 EIR is sent to the Office of Compliance, Center

for Devices and Radiological Health (CDRH)


 Inspection is classified based on inspectional

findings
 Office of Compliance reviewer writes Warning

Letter for inspection classified OAI


25 Sept. 2003 Frankfurt, Germany 28

How does FDA classify inspection reports?


 NAI No action indicated  VAI Voluntary action indicated some

deficiencies identified but not serious


 OAI Official action indicated

serious deficiencies identified, and FDA must take action to assure correction
25 Sept. 2003 Frankfurt, Germany 29

What actions can FDA take to address OAI inspections?


 For device manufacturers

outside the U.S.:


 Warning  Warning

Letter

Letter + Automatic Detention

25 Sept. 2003

Frankfurt, Germany

30

Warning Letter
 FDA sends Warning Letter

describing manufacturers violations of FDA regulations and requesting a reply within 15 days

25 Sept. 2003

Frankfurt, Germany

31

Warning Letter + Automatic Detention


 FDA sends Warning Letter describing

manufacturers violations of FDA regulations and requesting a reply within 15 days


 Manufacturers products

are put on automatic detention to prevent them from entering the U.S.
25 Sept. 2003 Frankfurt, Germany 32

What will the Warning Letter say about Automatic Detention?


 Given the serious nature of these violations of

the Act, all products manufactured at this facility may be detained without physical examination upon entry into the United States. In order to prevent your devices from being detained without physical exam, your firm will need to respond to this Warning Letter (as set forth below) and correct the violations noted in this letter. In addition, the agency usually needs to conduct a follow-up inspection to verify that the appropriate corrections have been implemented.
25 Sept. 2003 Frankfurt, Germany 33

How do I get my devices off automatic detention?


 Submit documentation to FDA showing

that deficiencies have been corrected


 FDA will inspect you to confirm that

corrections are adequate before lifting automatic detention

25 Sept. 2003

Frankfurt, Germany

34

Where can I get more information about FDA inspections and regulations?
 QSIT:


http://www.fda.gov/ora/inspect_ref/igs/qsit/QSI TGUIDE.PDF http://www.fda.gov/ora/inspect_ref/igs/qsit/qsit guide.htm

 Inspections of Medical Device Manufacturers

Compliance Program 7382.845: http://www.fda.gov/ora/cpgm/default.htm#devi ces More . . .


25 Sept. 2003 Frankfurt, Germany 35

Where can I get more information about FDA inspections and regulations?
 Quality system regulation:

http://www.accessdata.fda.gov/scripts/cdrh/cf docs/cfcfr/CFRSearch.cfm?CFRPart=820
 General quality system info:

http://www.fda.gov/cdrh/devadvice/32.html
 Investigations Operations Manual:

http://www.fda.gov/ora/inspect_ref/iom/default .htm More . . .


25 Sept. 2003 Frankfurt, Germany 36

Where can I get more information about FDA inspections and regulations?
 Other medical device regulations:

http://www.fda.gov/cdrh/devadvice/
 Division of Small Manufacturers, International

and Consumer Assistance - E-mail: dsma@cdrh.fda.gov


 Christine Nelson E-mail: mcn@cdrh.fda.gov

25 Sept. 2003

Frankfurt, Germany

37

Summary
 Quality System Inspection Technique (QSIT)  How FDA conducts inspections  What should a manufacturer do after an

inspection
 Warning Letter or Warning Letter + Automatic

Detention
 Where to go for more information
25 Sept. 2003 Frankfurt, Germany 38

You might also like